NEW YORK (TheStreet) -- RATINGS CHANGES
Alkermes (ALKS) - Get Report was downgraded at Morgan Stanley to underweight from equal-weight. Twelve-month price target is $61. New products could underperform and the company is facing increased generic competition, Morgan Stanley said.
was upgraded at Morgan Stanley to overweight from equal-weight. Twelve-month price target is $56. Stock is down on regulatory risks, but expect no material fallout, Morgan Stanley said.
Meritage Homes (MTH) - Get Report was downgraded at Citigroup to hold from buy. Twelve-month price target is $47. Company has 30% exposure to Texas, which could be hurt by lower energy prices, Citigroup said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.
This article was written by a staff member of TheStreet.